Literature DB >> 7902053

Principles of synaptic transmission.

R Y Moore1.   

Abstract

Neurons in the central nervous system communicate almost exclusively by the production and release at synapses of a series of molecules that are designated transmitters. Three such molecules make up the major transmitters, GABA, glutamate, and acetylcholine. GABA neurons are the principal inhibitory neurons and, as such, are the major local circuit neurons of the brain. They also are projection neurons in a number of systems. Glutamate neurons are excitatory projection neurons, particularly of the cerebral cortex, thalamus and retina. Acetylcholine neurons are excitatory neurons in ascending brainstem and basal forebrain systems and in cranial and spinal motor neurons and neurons of the sympathetic and parasympathetic systems. The catecholamines, dopamine and norepinephrine, are transmitters in several systems in brain. Dopamine is present in midbrain neurons projecting to the neostriatum, basal forebrain and cerebral cortex. It is also produced by hypothalamic neurons projecting to the median eminence and pituitary. These systems are highly topographically organized in contrast to the norepinephrine systems. The locus coeruleus norepinephrine system projects principally to thalamus, cerebral cortex and cerebellar cortex whereas the lateral tegmental system projects primarily to basal forebrain, hypothalamus, brainstem and spinal cord. The serotonin neurons of the brainstem raphe also project widely over the neuraxis, midbrain raphe neurons primarily to diencephalon and telencephalon and pontine medullary neurons to brainstem and spinal cord. There are smaller neuronal groups that produce glycine or histamine. At the present time, it appears that most, if not all, CNS neurons produce one of these small molecule transmitters. In many instances, these molecules are colocalized with one or more peptides that appear to modify the postsynaptic action of the small molecule transmitter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902053     DOI: 10.1111/j.1749-6632.1993.tb23018.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Imaging of glutamate in brain slices using FRET sensors.

Authors:  Chris Dulla; Hiroaki Tani; Sakiko Okumoto; Wolf B Frommer; Rich J Reimer; John R Huguenard
Journal:  J Neurosci Methods       Date:  2007-11-06       Impact factor: 2.390

2.  Synaptic Adhesion Molecule Pcdh-γC5 Mediates Synaptic Dysfunction in Alzheimer's Disease.

Authors:  Yanfang Li; Zhicai Chen; Yue Gao; Gaojie Pan; Honghua Zheng; Yunwu Zhang; Huaxi Xu; Guojun Bu; Hui Zheng
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

Review 3.  Sleep disturbances in Alzheimer's and Parkinson's diseases.

Authors:  Sarah M Rothman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2012-05-03       Impact factor: 3.843

4.  Neuronal activity regulates viral replication of herpes simplex virus type 1 in the nervous system.

Authors:  Cheryl X Zhang; Harrison Ofiyai; Ming He; Xuexian Bu; Yanhua Wen; William Jia
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

Review 5.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

Review 6.  GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.

Authors:  Mauricio O Nava-Mesa; Lydia Jiménez-Díaz; Javier Yajeya; Juan D Navarro-Lopez
Journal:  Front Cell Neurosci       Date:  2014-06-25       Impact factor: 5.505

7.  The Kinetic Component in Drug Discovery: Using the Most Basic Pharmacological Concepts to Advance in Selecting Drugs to Combat CNS Diseases.

Authors:  Rafael Franco; Josema Castelló; Enric I Canela
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 8.  Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease.

Authors:  Ramsey Najm; Emily A Jones; Yadong Huang
Journal:  Mol Neurodegener       Date:  2019-06-11       Impact factor: 14.195

9.  Real-time imaging of glutamate transients in the extracellular space of acute human brain slices using a single-wavelength glutamate fluorescence nanosensor.

Authors:  Anna Maslarova; Andreas Stadlbauer; Sebastian Brandner; Simon Aicher; Sarah Schroeter; Izabela Swierzy; Thomas M Kinfe; Michael Buchfelder
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.